142 related articles for article (PubMed ID: 38109477)
21. Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma.
de Wilde RF; Ottenhof NA; Jansen M; Morsink FH; de Leng WW; Offerhaus GJ; Brosens LA
Mod Pathol; 2011 Sep; 24(9):1229-36. PubMed ID: 21572398
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic Ductal Adenocarcinoma in Remnant Pancreas after Pancreaticoduodenectomy for Acinar Cell Carcinoma: A Case Report.
Nishimura S; Utsumi M; Aoki H; Une Y; Kashima H; Kimura Y; Taniguchi F; Arata T; Katsuda K; Tanakaya K; Sato Y
J Nippon Med Sch; 2019 Dec; 86(5):279-283. PubMed ID: 31061255
[TBL] [Abstract][Full Text] [Related]
23. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic Mixed Acinar-neuroendocrine-ductal Carcinoma: A Case Report and Literature Review.
Sakaguchi R; Yamada R; Nose K; Tanaka T; Murashima Y; Tsuboi J; Nakagawa H
Intern Med; 2023 Nov; 62(22):3347-3353. PubMed ID: 37032087
[TBL] [Abstract][Full Text] [Related]
25. Surgical and molecular pathology of pancreatic neoplasms.
Hackeng WM; Hruban RH; Offerhaus GJ; Brosens LA
Diagn Pathol; 2016 Jun; 11(1):47. PubMed ID: 27267993
[TBL] [Abstract][Full Text] [Related]
26. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic acinar cell carcinoma with a ductal adenocarcinoma component: a case report and analysis of the histogenesis of the tumor.
Kimura T; Tabata S; Togawa T; Onchi H; Iida A; Sato Y; Goi T
World J Surg Oncol; 2020 Sep; 18(1):238. PubMed ID: 32891173
[TBL] [Abstract][Full Text] [Related]
28. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
Golan T; O'Kane GM; Denroche RE; Raitses-Gurevich M; Grant RC; Holter S; Wang Y; Zhang A; Jang GH; Stossel C; Atias D; Halperin S; Berger R; Glick Y; Park JP; Cuggia A; Williamson L; Wong HL; Schaeffer DF; Renouf DJ; Borgida A; Dodd A; Wilson JM; Fischer SE; Notta F; Knox JJ; Zogopoulos G; Gallinger S
Gastroenterology; 2021 May; 160(6):2119-2132.e9. PubMed ID: 33524400
[TBL] [Abstract][Full Text] [Related]
29. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma.
Schmidt CM; Matos JM; Bentrem DJ; Talamonti MS; Lillemoe KD; Bilimoria KY
J Gastrointest Surg; 2008 Dec; 12(12):2078-86. PubMed ID: 18836784
[TBL] [Abstract][Full Text] [Related]
30. [Pancreatic acinar cell carcinoma: diagnostic and surgical treatment strategy].
Guo JC; Zhan HX; Zhang TP; Zhao YP
Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):221-4. PubMed ID: 23859322
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
[TBL] [Abstract][Full Text] [Related]
32. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability.
Jäkel C; Bergmann F; Toth R; Assenov Y; van der Duin D; Strobel O; Hank T; Klöppel G; Dorrell C; Grompe M; Moss J; Dor Y; Schirmacher P; Plass C; Popanda O; Schmezer P
Nat Commun; 2017 Nov; 8(1):1323. PubMed ID: 29109526
[TBL] [Abstract][Full Text] [Related]
34. Successful BRAF/MEK inhibition in a patient with
Busch E; Kreutzfeldt S; Agaimy A; Mechtersheimer G; Horak P; Brors B; Hutter B; Fröhlich M; Uhrig S; Mayer P; Schröck E; Stenzinger A; Glimm H; Jäger D; Springfeld C; Fröhling S; Zschäbitz S
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843432
[TBL] [Abstract][Full Text] [Related]
35. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.
Furukawa T; Sakamoto H; Takeuchi S; Ameri M; Kuboki Y; Yamamoto T; Hatori T; Yamamoto M; Sugiyama M; Ohike N; Yamaguchi H; Shimizu M; Shibata N; Shimizu K; Shiratori K
Sci Rep; 2015 Mar; 5():8829. PubMed ID: 25743105
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association.
Gaujoux S; Tissier F; Ragazzon B; Rebours V; Saloustros E; Perlemoine K; Vincent-Dejean C; Meurette G; Cassagnau E; Dousset B; Bertagna X; Horvath A; Terris B; Carney JA; Stratakis CA; Bertherat J
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1888-95. PubMed ID: 21900385
[TBL] [Abstract][Full Text] [Related]
37. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin
Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J
Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317
[TBL] [Abstract][Full Text] [Related]
38. Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib: A case report.
Li M; Mou Y; Hou S; Cao D; Li A
Medicine (Baltimore); 2018 Nov; 97(45):e13113. PubMed ID: 30407325
[TBL] [Abstract][Full Text] [Related]
39. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report.
Shimmura H; Kuramochi H; Jibiki N; Katagiri S; Nishino T; Araida T
Jpn J Clin Oncol; 2019 Dec; 49(11):1049-1054. PubMed ID: 31612916
[TBL] [Abstract][Full Text] [Related]
40. Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.
Nießen A; Schimmack S; Weber TF; Mayer P; Bergmann F; Hinz U; Büchler MW; Strobel O
Pancreatology; 2021 Jan; 21(1):224-235. PubMed ID: 33309225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
